[Advances in studies on pharmacokinetics of scutellarin and scutellarein].
Jianming Liu, Yuqing Xiong
Index: Zhongguo Zhong Yao Za Zhi 34(24) , 3165-8, (2009)
Full Text: HTML
Abstract
Scutellarin is the major effective ingredient of breviscapine, which is widely used in the treatment of cardiovascular diseases and has a remarkable achievement. In recent years, more and more reseaches had focused on the pharmacokinetics of scutellarin and scutellarein. The article summarized the studies on pharmacokinetics of scutellarin and scutellarein have been performed by domestic and oversea scholars.
Related Compounds
Related Articles:
2015-01-01
[J. Neuroinflammation 12 , 11, (2015)]
2013-03-01
[Zhongguo Zhong Yao Za Zhi 38(6) , 817-20, (2013)]
2013-01-01
[Molecules 18(1) , 545-60, (2013)]
2010-01-01
[J. Pharm. Biomed. Anal. 95 , 93-101, (2014)]
2015-04-22
[J. Ethnopharmacol. 164 , 301-8, (2015)]